1,3-Dipolar cycloaddition approach to the construction of new bis-heterocycles from thymine as potential non-nucleoside reverse transcriptase inhibitors

Abstract

In the search for new anti-HIV agents, a synthetic route to novel acyclic (flexible) and tricyclic bis-heterocycles has been explored involving in the key steps the [3 + 2] cycloaddition reaction of the N-3 thymine-substituted enamines 34, 36 and 39 with the nitrile oxide 11, and the ring closure of the isoxazole amide derivatives 49 and 51 to the diazepine 10a, and the diazocine 10b. A number of competing reactions were also encountered during the construction of compounds 10. These include a fragmentation process wherein the 1-azadienes 38 and 46 are formed, and base-promoted rearrangement of the isoxazole ring in intermediates 50 and 59 to give the bicyclic thymine derivative 53 and the tricyclic succinimide derivative 60, respectively. Radical cyclisation of the guanidine amide 52 to isoxazole 57 on reaction with isoamyl nitrite in warm DMF was also observed.

References

1. R. C. Gallo, S. Z. Salahuddin, M. Popovic, G. M. Shearer, M. Kaplan, F. H. Barton, J. P. Thomas, R. Redfielg, J. Oleske, B. Safai, G. White, P. Foster and P. D. Markham, Science, 1984, 224, 500.
2. F. Barré-Sinousi, J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vézinet-Brun, C. Rouzioux, W. Rozenbaum and L. Montagnier, Science, 1983, 220, 868.
3. P. Chandra, A. Vogel and T. Gerber, Cancer Res., 1985, 45(Suppl.), 4677s; S. P. Goff, J. Acquired Immune Defic. Syndr., 1990, 3, 817; A. Jacobo-Molina and E. Arnold, Biochemistry, 1991, 30, 6351.
4. H. Mitsuya, K. J. Weinhold, P. A. Furman, M. H. St. Clair, S. Nusiniff-Lehrman, R. C. Gallo, D. Bolognesi, D. W. Barry and S. Broder, Proc. Natl. Acad. Sci. USA, 1985, 82, 7096.
5. R. Yarchoan, H. Mitsuya, R. V. Thomas, J. M. Pluda, N. R. Hartman, C. F. Perno, K. S. Marczyk, J.-P. Allain, D. G. Johns and S. Broder, Science, 1989, 245, 412.
6. H. Mitsuya and S. Broder, Proc. Natl. Acad. Sci. USA, 1986, 83, 1911.
7. M. Nasr, C. Litterst and J. McGowan, J. Antiviral Res., 1990, 14, 125; D. M. Huryn and K. Okabe, Chem. Rev., 1992, 92, 1745.
8. Y. Cheng, G. E. Dutschman, K. F. Bastow, M. G. Sarngadharan and Y. R. C. Ting, J. Biol. Chem., 1987, 262, 2187; M. H. St. Clair, C. A. Richards, T. Spector, K. J. Weinhold, W. H. Miller, A. J. Langlois and P. A. Furman, Antimicrob. Agents Chemother., 1987, 31, 1972; P. Huang, D. Farquhar and W. Plunkett, J. Biol. Chem., 1990, 265, 11 914; P. A. Furman, J. A. Fyfe, M. H. St. Clair, K. Weinhold, J. L. Rideout, G. A. Freeman, S. Nusinoff-Lehrman, D. P. Bolognesi, S. Broder, H. Mitsuya and D. W. Barry, Proc. Natl. Acad. Sci. USA, 1986, 83, 8333.
9. R. Pauwels, K. Andries, J. Desmyter, D. Schols, M. J. Kukla, H. J. Breslin, A. Raeymaeckers, J. Van Gelder, R. Woestenborghs, J. Heykants, K. Schellekens, M. A. C. Janssen, E. DeClerq and P. A. J. Janssen, Nature, 1990, 343, 470.
10. D. L. Romero, R. A. Morge, C. Biles, N. Berrios-Pena, P. D. May, J. R. Palmer, P. D. Johnson, H. W. Smith, M. Busso, C. H. Tan, R. L. Voorman, F. Reuser, I. W. Althaus, K. M. Downey, A. G. So, L. Resnick, W. G. Tarpley and P. A. Aristoff, J. Med. Chem., 1994, 37, 999.
11. R. Pauwels, K. Andries, Z. Bebyser, P. V. Van Daele, D. Schols, P. Stoffels, K. Vreese, R. Woestenborghs, A. M. Vandamme, C. G. M. Janssen, J. Anne, G. Cauwenbergh, J. Desmyter, J. Heykants, M. A. C. Janssen, E. De Clercq and P. A. J. Janssen, Proc. Natl. Acad. Sci. USA., 1993, 90, 1711.
12. W. S. Saari, J. S. Wai, T. E. Fischer, C. M. Thomas, J. M. Hoffman, C. S. Rooney, A. M. Smith, J. H. Jones, D. L. Bamberger, M. E. Goldman, J. A. O'Brien, J. H. Nunberg, J. C. Quintero, W. A. Schleif, E. A. Emini and P. S. Anderson, J. Med. Chem., 1992, 35, 3792.
13. K. D. Hargrave, J. R. Proudfoot, K. G. Grozinger, E. Cullen, S. R. Kapadia, U. R. Patel, V. U. Fuchs, S. C. Mauldin, J. Vitous, M. L. Behnke, J. M. Klunder, K. Pal, J. W. Skiles, D. W. McNeil, J. M. Rose, G. C. Chow, M. T. Skoog, J. C. Wu, G. Schmidt, W. W. Engel, W. G. Eberlein, T. D. Saboe, S. J. Campbell, A. S. Rosenthal and J. Adams, J. Med. Chem., 1991, 34, 2231.
14. D. D. Richman, Annu. Rev. Pharmacol. Toxicol., 1993, 32, 149; E. De Clercq, Biochem. Pharmacol., 1994, 47, 155; J. Med. Chem., 1995, 38, 2491.
15. R. E. Dornsife, M. H. St. Clair, A. T. Huang, T. J. Panella, G. W. Koszalka, C. L. Burns and D. R. Averet, Antimicrob. Agents Chemother., 1991, 35, 322; G. Antonelli, F. Dianzani, D. Bellarosa, O. Turriziani, E. Riva and A. Gentile, Antimicrob. Agents Chemother., 1994, 38, 51; J. C. Craig, I. B. Duncan, L. Whittaker and N. A. Roberts, Antimicrob. Agents Chemother., 1993, 37, 161; M. Baba, M. Ito, S. Shigeta, H. Tanaka, T. Miyasaka, M. Ubasawa, K. Umezu, R. T. Walker and E. De Clercq, Antimicrob. Agents Chemother., 1991, 35, 1430; R. W. Buckleit, E. L. White, J. Germany-Decker, L. B. Allen, L. J. Ross, W. M. Shannon, P. A. J. Janssen and M. A. Chirigos, Antimicrob. Agents Chemother., 1994, 38, 35; D. D. Richman, A. S. Rosenthal, M. Skoog, R. J. Eckner, T.-C. Chou, J. P. Sabo and V. J. Merluzzi, Antimicrob. Agents Chemother., 1991, 35, 305; K.-T. Chong, P. J. Pagano and R. R. Hinshaw, Antimicrob. Agents Chemother., 1994, 38, 288; Y.-K. Chow, M. S. Hirsh, D. P. Merrill, L. J. Bechtel, J. J. Eron, J. C. Kaplan and R. T. D'Aquila, Nature, 1993, 361, 650.
16. A. P. Kozikowski and M. Adamczyk, J. Org. Chem., 1983, 48, 366.
17. M. K. Meilahn, B. Cox and M. E. Funk, J. Org. Chem., 1975, 40, 819.
18. R. C. Smith and S. B. Binkley, J. Org. Chem., 1959, 24, 249.
19. A. I. Meyers, R. L. Nolen, E. W. Collington, T. A. Narwid and R. C. Strickland, J. Org. Chem., 1973, 38, 1974.
20. D. B. Dess and J. C. Martin, J. Am. Chem. Soc., 1991, 113, 7277; S. D. Meyer and S. L. Schreiber, J. Org. Chem., 1994, 59, 7549.
21. R. T. Brown and J. A. Joule, Comprehensive Organic Chemistry, ed. D. Barton and W. D. Ollis, Pergamon Press, Oxford, 1979, vol. 4, p. 453; J. H. Brewster and E. L. Eliel, Org. React, 1953, 7, 99.
22. J. L. Wong and D. S. Fuchs, J. Org. Chem., 1970, 35, 3786.
23. H. Vanderhaeghe and M. Claesen, Bull. Soc. Chim. Belg., 1959, 68, 30.
24. M. Jung and C. Castro, J. Org. Chem., 1993, 58, 807.
25. (a) K. C. Majumdar, S. K. Chattopadhyay and A. K. Gupta, Indian. J. Chem., Sect. B, 1990, 29, 1138; (b) S. J. De Melo and C. Luu-Duc, J. Chem. Res. (S), 1992, 286; (c) B. Abarca, M. Jimenez, G. Jones and C. Soriano, J. Chem. Res. (M), 1986, 3358; M. Gacek and K. Undheim, Acta Chem. Scand., Ser. B, 1982, 36, 15; G. C. Hopkins, J. P. Jonak, H. Tieckelmann and H. J. Minnemeyer, J. Org. Chem., 1966, 31, 3969.
26. J.-E. Nyström, T. D. McCanna, P. Helquist and R. Amouroux, Synthesis, 1988, 56.
27. F. Seela and U. Bindy, Liebigs Ann. Chem., 1989, 895.
28. Concerning the stability of related 1-azadienes see: M. Teng and F. W. Fowler, J. Org. Chem., 1990, 55, 5646; N. J. Sisti, F. W. Fowler and D. S. Grierson, Synlett, 1991, 816; C. Trione, L. M. Toledo, S. Kuduk, F. W. Fowler and D. S. Grierson, J. Org. Chem., 1993, 58, 2075.
29. P. D. Croce, C. La Rosa and R. Destro, J. Chem. Soc., Perkin Trans. 1, 1990, 679.
30. R. Taylor, J. Chem. Soc., Perkin Trans. 2, 1975, 1025.
31. H. Maehr, M. Leach and V. Toome, J. Heterocycl. Chem., 1972, 9, 1389.
32. P. Grünanger and P. Vita-Finzi, The Chemistry of Heterocyclic Compounds Isoxazoles Part I, ed. E. C. Taylor and A. Weissberger, Wiley, New York, 1991; S. A. Lang, Jr. and Y.-I. Lin, Comprehensive Heterocyclic Chemistry, ed. A. Katritsky and C. Rees, Pergamon Press, Oxford, 1984, vol. 6, p. 1; C. Perez, Y. L. Janin and D. S. Grierson, Tetrahedron, 1996, 52, 987.
33. V. Nair and S. G. Richardson, Synthesis, 1982, 670; J. Saunders, M. Cassidy, S. B. Freedman, E. A. Harley, L. L. Iversen, C. Kneen, A. M. MacLeod, K. J. Merchant, R. J. Snow and R. Baker, J. Med. Chem., 1990, 33, 1128; K. Tanji, H. Kato and T. Higashino, Chem. Pharm. Bull., 1991, 39, 3037.
34. G. Fillipi, G. Vernin, H. J.-M. Dou and J. Metzger, Bull. Soc. Chim. Fr., 1974, 1075.
35. G. Vernin, H. J.-M. Dou and J. Metzger, Bull. Soc. Chim. Fr., 1972, 1173.
36. A. Quilico and M. Freri, Gazz. Chim. Ital., 1946, 76, 3.
37. C. Moog, A. Wick, P. Le Ber, A. Kim and A. M. Aubertin, Antiviral Res., 1994, 24, 275.
38. J. Ding, K. Das, H. Moereels, L. Koymans, K. Andries, P. A. J. Janssen, S. H. Hughes and E. Arnold, Structural Biol., 1995, 2, 407.
39. For modification of nevirapine leading to analogues active against the Tyr181→Cys resistant strain see: J. R. Proudfoot, K. D. Hargrave, S. R. Kapadia, U. R. Patel, K. G. Grozinger, D. W. McNeil, E. Cullen, M. Cardozo, L. Tong, T. A. Kelly, J. Rose, E. David, S. C. Mauldin, V. U. Fuchs, J. Vitous, M. Hoermann, J. M. Klunder, P. Raghavan, J. W. Skiles, P. Mui, D. D. Richman, J. L. Sullivan, C.-K. Shih, P. M. Grob and J. Adams, J. Med. Chem., 1995, 38, 4830; T. A. Kelly, J. R. Proudfoot, D. W. McNeil, U. R. Patel, E. David, K. D. Hargrave, P. M. Grob, M. Cardozo, A. Agarwal and J. Adams, J. Med. Chem., 1995, 38, 4839.
40. For a related series of compounds see: M. Artico, R. Silvestri, S. Massa, A. G. Loi, S. Corrias, G. Piras and P. Lacolla, J. Med. Chem., 1996, 39, 522.